Form D · Pharmaceuticals

Callidus Biopharma, Inc.

Doylestown, PA · CIK 0001539849

Offering snapshot reported Apr 12, 2013 · SEC filing

Reported sold
$4.61M
Offering amount: $5M
Investors reported
8
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
Jan 4, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.31M$4.61MJan 18, 2012: $1,445,000.00Jan 18, 2012Jul 2, 2012: $1,611,154.00Jul 2, 2012Mar 19, 2013: $3,611,154.00Apr 12, 2013: $4,611,154.00Apr 12, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,445,000 → $4,611,154
  • Reported investors5 → 8
  • Minimum accepted$25,000 → $20,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 12, 2013Amendment$4,611,154$3,166,154vs Jan 18, 20128SEC filing
Mar 19, 2013Amendment$3,611,154$2,166,154vs Jan 18, 20128SEC filing
Jul 2, 2012Amendment$1,611,154$166,154vs Jan 18, 20128SEC filing
Jan 18, 2012Initial$1,445,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$222K
Finders' fees
$0
Form D file number
021-172083
Plus warrants to purchase 22,498 shares of Series A Preferred Stock at $7.6923 per share. If remainder of the total offering amount is sold, $27, 219 in cash commissions and 2,780 additional warrants would be paid.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Walter Greenblatt & Associates, LLC129291

Source: Form D, filed Apr 12, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cuong Do Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3805 Old Easton Road
Doylestown, PA, 18902